Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer

Despite the recent advances in the management of cervical cancer using cisplatin-based concurrent chemoradiotherapy, substantial treatment failure still occurs, especially in advanced-stage patients and early-stage cervical cancer patients with high-risk prognostic factors. Therefore, efforts to fur...

Descripción completa

Detalles Bibliográficos
Autores principales: Mabuchi, Seiji, Kimura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265244/
https://www.ncbi.nlm.nih.gov/pubmed/22312560
http://dx.doi.org/10.1155/2011/963159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265244/
https://www.ncbi.nlm.nih.gov/pubmed/22312560
http://dx.doi.org/10.1155/2011/963159

Ejemplares similares